NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Long-term Investment Intensity
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Long-term Investment Intensity of 6.8% as of September 2025. Long-term investments of $53.09 Million represent 6.8% of total assets of $786.43 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check NAMS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares (None–None)
The table below presents the year-by-year Long-term Investment Intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NewAmsterdam Pharma Company N.V. Ordinar stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|